Wilson Sonsini advised RxSight, and Davis Polk advised the sole bookrunning manager in the offering. RxSight, Inc. announced a $50 million SEC-registered follow-on offering of 4,000,000...
RxSight’s $50 Million Common Shares Offering
Xponential Fitness’ $122.5 Million Secondary Offering of Class A Common Stock
Davis Polk is advising Xponential Fitness on the offering, and Latham & Watkins is advising the underwriters involved. Xponential Fitness, Inc. has announced the pricing of...
Pacific Biosciences’ $201.25 Million Stock Offering
Wilson Sonsini advised Pacific Biosciences of California on the offering, and Davis Polk advised the representatives of the several underwriters involved. Pacific Biosciences of California Inc. announced...
Xponential Fitness’ $131 Million Preferred Stock Repurchase
Davis Polk advised Xponential Fitness Inc. on the repurchase and a new $130 million credit facility. Xponential Fitness Inc. announced a privately negotiated preferred stock repurchase...
Flex’s $400 Million Notes Offering
Davis Polk advised the joint book-running managers in the offering. Flex Ltd. executed a $400 million SEC-registered debt offering. The offering consisted of $400 million aggregate principal amount...
Amazon.com’s $8.25 Billion Notes Offering
Gibson, Dunn & Crutcher advised Amazon.com, while Davis Polk advised the representatives of the underwriters in the offering. Amazon.com, Inc. executed its offering, consisting of $1.25...
RAPT Therapeutics’ $75 Million Common Stock Offering
Cooley advised RAPT Therapeutics, while Davis Polk advised the joint book-running managers in the offering. RAPT Therapeutics, Inc. executed a $75 million SEC-registered follow-on offering of 4,054,055...
Natera’s $400 Million Shares Offering
Davis Polk advised the representatives of the several underwriters in the offering. Natera, Inc. announced its follow-on offering of 11,430,000 shares of common stock for total gross...
Tenaya Therapeutics’ $75 Million Shares Offering
Wilson Sonsini Goodrich & Rosati advised Tenaya on the deal, while Davis Polk advised the joint book-running managers and representatives of the several underwriters. Clinical stage...
Snail’s $15 Million Initial Public Offering
Davis Polk advised Snail on the deal. Snail, Inc. executed its SEC-registered initial public offering of 3,000,000 shares of Class A common stock for total gross...
Equinix’s $1.5 Billion At-The-Market Offering
Davis Polk advised Equinix, Inc. on the offering. Equinix, Inc. announced its SEC-registered at-the-market offering program. Pursuant to the terms of the program, Equinix may issue, offer and/or...
Abiomed’s $18 Billion Merger Agreement with Johnson & Johnson
Sullivan & Cromwell advised Abiomed on the deal, while Cravath represented Johnson & Johnson. Davis Polk advised J.P. Morgan Securities LLC as financial adviser to Johnson...